, /PRNewswire/ -- Neuros Medical, Inc., the maker of the Altius® Direct Electrical Nerve Stimulation System designed for patients with chronic post-amputation pain, today announced the appointment of , Chief Financial Officer (CFO); , Vice President of U.S.
Sales; and , Vice President of Marketing. "I am thrilled to welcome Zach, Kirk, and Steve to the Neuros team and believe their proven track records commercializing disruptive technologies and building successful companies will add significant value to our organization. These experienced teammates join us at a critical time as we expand our commercial team and prepare to launch the Altius® System in the U.
S.," said , President and CEO of Neuros Medical. Messrs.
Stassen, Ellis, and Bosrock bring a combined 65 years of experience in medical devices to the Neuros team and have played pivotal leadership roles in numerous successful product launches and in building companies acquired by , Boston Scientific, Cardinal Health, Hologic, Johnson and Johnson, Medtronic, and . Mr. Stassen brings more than 20 years of finance, operations, and leadership experience to his new role at Neuros Medical.
Most recently, he served as Chief Financial Officer for ViewRay, Inc., a publicly traded company focused on cancer treatment. Prior to ViewRay, he served as Chief Financial Officer and Chief Operating Officer for Bolder Surgical, an innovative, privately held surgical instrument company that was acquired by Hologic.
Prior to Bolder Surgical.
